Overview

A Safety Study Looking at the Combination of Velcade and G-CSF in Patients With Myeloma or Lymphoma

Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if the combination of G-CSF and bortezomib is safe and effective in blood cell mobilization.
Phase:
Early Phase 1
Details
Lead Sponsor:
University of Kansas
University of Kansas Medical Center
Collaborator:
Millennium Pharmaceuticals, Inc.
Treatments:
Bortezomib
Lenograstim